1452-P: Type 1 Diabetes Subphenotypes—A Cluster Analysis
KATSIARYNA PRYSTUPA, Róbert Wágner(Deutsches Diabetes-Zentrum e.V.), Julia Szendroedi(Deutsches Diabetes-Zentrum e.V.), Michael Roden(Düsseldorf University Hospital), Sebastian M. Meyhöfer, Maximilian Huttasch(Deutsches Diabetes-Zentrum e.V.), Klaus Straßburger(Deutsches Diabetes-Zentrum e.V.), Michael Stümvoll(IFB Adiposity Diseases), Andreas Fritsche(University of Tübingen), Oana‐Patricia Zaharia(Düsseldorf University Hospital), Volker Burkart(Deutsches Diabetes-Zentrum e.V.), ANDREAS F. PFEIFFER, ALEXANDER STROM, GIDON J. BÖNHOF, Martin Heni(University Children's Hospital Tübingen), Nina Saatmann(Deutsches Diabetes-Zentrum e.V.), Jochen Seißler
Cited by 0
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
The integrative biology of type 2 diabetes
|Nature|2019|1.1k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Annals of Hepatology|2023|789